Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
130A Veritas In Silico
- 882
- +150+20.49%
20min DelayMarket Closed Dec 30 15:30 JST
5.72BMarket Cap146.76P/E (Static)
882High739Low583.70KVolume739Open732Pre Close495.62MTurnover347552wk High35.82%Turnover Ratio6.49MShares63752wk Low6.01EPS TTM1.44BFloat Cap3475Historical High146.76P/E (Static)1.63MShs Float637Historical Low6.01EPS LYR19.54%Amplitude--Dividend TTM2.43P/B100Lot Size--Div YieldTTM
About Veritas In Silico Company
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
Company Profile
Symbol130A
Company NameVeritas In Silico
Founded2016-11-17
MarketTSE Growth
Fiscal Year Ends12-31
Address1-11-1, Nishigotanda Shinagawa-ku
Zip Code141-0031
Phone03-6421-7537
Websitewww.veritasinsilico.com
Company Executives
- Name
- Position
- Salary
- Shingo Nakamura
- Representative Director and President
- --
- Hiroyuki Matsuoka
- Director and Head of Management Headquarters
- --
- Takashi Uemura
- Director and Head of Business Headquarters
- --
- Kinichiro Konami
- Non-Executive Independent Director
- --